Inorganic Growth Strategies is a Key Trend Gaining Market Momentum
1h Free Analyst Time
The global celiac diseases drugs market is forecasted to grow by USD 701.59 million during 2022-2027, accelerating at a CAGR of 17.01% during the forecast period. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac diseases, and government initiatives.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
The global celiac diseases drugs market is segmented as below:
By Therapy
- First line treatment
- Second-line treatment
By Route Of Administration
- Oral
- Parenteral
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the celiac diseases drugs market covers the following areas:
- Celiac diseases drugs market sizing
- Celiac diseases drugs market forecast
- Celiac diseases drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The research team recognizes the following companies as the key players in the global celiac diseases drugs market: 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech BV, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ImmunogenX Inc., Johnson and Johnson, Precigen Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, and Zedira GmbH.One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is inorganic growth strategies.'
According to the report, one of the major drivers for this market is the higher consumption of gluten-containing food.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 9 Meters Biopharma Inc.
- Adaptive Biotechnologies Corp.
- Almirall SA
- Amgen Inc.
- AMYRA Biotech AG
- Artielle Immunotherapeutics Inc.
- Avaxia Biologics Inc.
- BioLineRx Ltd.
- Bristol Myers Squibb Co.
- Calypso Biotech BV
- GlaxoSmithKline PLC
- Glenmark Pharmaceuticals Ltd.
- ImmunogenX Inc.
- Johnson and Johnson
- Precigen Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vactech Oy
- Zedira GmbH